Your browser doesn't support javascript.
loading
Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma.
Mendiola, Marta; Saarela, Jani; Escudero, Francisco Javier; Heredia-Soto, Victoria; Potdar, Swapnil; Rodriguez-Marrero, Silvia; Miguel, Maria; Pozo-Kreilinger, Jose Juan; Berjon, Alberto; Ortiz-Cruz, Eduardo; Feliu, Jaime; Redondo, Andres.
Afiliação
  • Mendiola M; Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Institute of Health Carlos III, Madrid, Spain. Ele
  • Saarela J; Institute for Molecular Medicine Finland (FIMM), Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, Helsinki 00290, Finland.
  • Escudero FJ; Translational Oncology Research Laboratory, IdiPAZ, Madrid, Spain.
  • Heredia-Soto V; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Institute of Health Carlos III, Madrid, Spain; Translational Oncology Research Laboratory, IdiPAZ, Madrid, Spain.
  • Potdar S; Institute for Molecular Medicine Finland (FIMM), Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, Helsinki 00290, Finland.
  • Rodriguez-Marrero S; Translational Oncology Research Laboratory, IdiPAZ, Madrid, Spain.
  • Miguel M; Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Pozo-Kreilinger JJ; Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain; Department of Pathology, La Paz University Hospital (HULP), Madrid, Spain.
  • Berjon A; Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain; Department of Pathology, La Paz University Hospital (HULP), Madrid, Spain.
  • Ortiz-Cruz E; Department of Orthopaedic Surgery, HULP, Madrid, Spain.
  • Feliu J; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Institute of Health Carlos III, Madrid, Spain; Translational Oncology Research Laboratory, IdiPAZ, Madrid, Spain; Department of Medical Oncology, HULP, Madrid, Spain; Cátedra UAM-ANGE
  • Redondo A; Translational Oncology Research Laboratory, IdiPAZ, Madrid, Spain; Department of Medical Oncology, HULP, Madrid, Spain; Cátedra UAM-ANGEM, School of Medicine, Autonomous University of Madrid, Madrid, Spain. Electronic address: andres.redondos@uam.es.
Biomed Pharmacother ; 173: 116397, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38479181
ABSTRACT
Angiosarcoma is a rare soft tissue sarcoma originating from endothelial cells. Given that current treatments for advanced disease have shown limited efficacy, alternative therapies need to be identified. In rare diseases, patient-derived cell models are crucial for screening anti-tumour activity. In this study, cell line models were characterised in 2D and 3D cultures. The cell lines' growth, migration and invasion capabilities were explored, confirming them as useful tools for preclinical angiosarcoma studies. By screening a drug library, we identified potentially effective compounds 8-amino adenosine impacted cell growth and inhibited migration and invasion at considerably low concentrations as a single agent. No synergistic effect was detected when combining with paclitaxel, gemcitabine or doxorubicin. These results suggest that this compound could be a potentially useful drug in the treatment of AGS.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Hemangiossarcoma Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Hemangiossarcoma Idioma: En Ano de publicação: 2024 Tipo de documento: Article